Hoag used Abbott’s Aveir leadless pacemaker system for the procedure, according to a Nov. 7 press release.
The pacemaker is smaller than a AAA battery and provides consistent atrioventricular synchrony, the coordinated contraction of the atria and ventricles of the heart that allow for proper heart function.
Nearly 80% of pacemaker patients require pacing in two chambers of the heart. Aveir offers beat-to-beat communication between the pacemakers in both chambers of the heart.
In a clinical trial, an average atrioventricular synchrony of at least 95% was achieved in patients.
The procedure was performed by Hoag clinical cardiac electrophysiologist Rajesh Banker, MD, who also served as the principal investigator in a trial of the pacemaker at Hoag.
Nearby system Orange, Calif.-based Providence St. Joseph Hospital also recently successfully implanted the system.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.